| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹29.23 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹29.23 Cr |
| Fresh Issue | ₹27.76 Cr |
| Face Value | โน10 Per Equity Share |
| Price Band | โน56.00-58.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | APRAMEYA |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | Hem Securities Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares and in multiples thereof
Incorporated in September 2003, Aprameya Engineering Limited installs and maintains Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centres. They provide these services on a turnkey basis and also supply high-value healthcare and diagnostic equipment to private hospitals, government hospitals, and medical practitioners.
Since 2020, the company has been setting up ICUs and operation theatres and has installed around 2000 critical care beds, including ICUs, NICUs, and PICUs, Modular operation theatres are being established throughout the state of Rajasthan.
The company has four warehouses: two in Memnagar, Ahmedabad, one in Prahladnagar, Ahmedabad and the fourth one on Ashram Road, Ahmedabad.
The company provides a wide range of medical equipment and solutions, such as an Electrosurgical Generator, Electrosurgical Unit, CO2 Insufflator, LED Surgery Light, Surgical and medical Examination Light, ICU Respiratory Monitoring System, ICU Ventilation System, Anesthesia Workstation, Jaundice Meter, Anesthesia Machine, and Harmonic Scale.
As of August 31, 2023, the company employed 44 permanent staff members responsible for day-to-day business operations, marketing, and accounting functions. business operations, marketing, and accounting functions.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | To meet incremental working capital requirements | 21.00 |
| 2 | General Corporate Purposes | 3.68 |
| Total | 24.68 |
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Assets | 75.60 | 61.89 | 48.71 |
| Total Income | 65.62 | 78.33 | 200.26 |
| Profit After Tax | 3.46 | 5.37 | 16.62 |
| NET Worth | 23.37 | 19.92 | 14.53 |
| Reserves and Surplus | 9.37 | 5.92 | 7.53 |
| Total Borrowing | 42.05 | 28.74 | 13.68 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 15.97% |
| ROCE | 9.60% |
| Debt / Equity | 1.80% |
| RoNW | 14.79% |
| PAT Margin | 5.30% |
| Price to Book Value | 3.48 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 2.47 | 1.82 |
| P/E (x) | 23.49 | 31.95 |
| Promoter Holding | 100% | 73.53% |
| Market Cap | โน110.43 Cr. | |